147 related articles for article (PubMed ID: 35149839)
1. Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
3. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
4. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
[TBL] [Abstract][Full Text] [Related]
5. Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.
Courbard JR; Fiore F; Adélaïde J; Borg JP; Birnbaum D; Ollendorff V
J Biol Chem; 2002 Nov; 277(47):45267-75. PubMed ID: 12226085
[TBL] [Abstract][Full Text] [Related]
6. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
8. CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN.
Li W; Lei T; Song X; Deng C; Lu J; Zhang W; Kuang Z; He Y; Zhou Q; Luo Z; Mo F; Yang H; Hang J; Xiao B; Li L
J Recept Signal Transduct Res; 2022 Dec; 42(6):588-598. PubMed ID: 36043996
[TBL] [Abstract][Full Text] [Related]
9. Cbl interacts with multiple E2s in vitro and in cells.
Liyasova MS; Ma K; Voeller D; Ryan PE; Chen J; Klevit RE; Lipkowitz S
PLoS One; 2019; 14(5):e0216967. PubMed ID: 31120930
[TBL] [Abstract][Full Text] [Related]
10. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
Do TV; Xiao F; Bickel LE; Klein-Szanto AJ; Pathak HB; Hua X; Howe C; O'Brien SW; Maglaty M; Ecsedy JA; Litwin S; Golemis EA; Schilder RJ; Godwin AK; Connolly DC
Oncogene; 2014 Jan; 33(5):539-49. PubMed ID: 23334327
[TBL] [Abstract][Full Text] [Related]
11. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
Zhou L; Yang H
PLoS One; 2011; 6(9):e23936. PubMed ID: 21949687
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.
Mu X; Zhang Y; Qu X; Hou K; Kang J; Hu X; Liu Y
Biomed Res Int; 2013; 2013():726375. PubMed ID: 23586056
[TBL] [Abstract][Full Text] [Related]
13. PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.
Zhang C; Qu L; Lian S; Meng L; Min L; Liu J; Song Q; Shen L; Shou C
Cancer Res; 2019 Mar; 79(5):928-940. PubMed ID: 30498084
[TBL] [Abstract][Full Text] [Related]
14. The Ubiquitin Ligase CBLC Maintains the Network Organization of the Golgi Apparatus.
Lee WY; Goh G; Chia J; Boey A; Gunko NV; Bard F
PLoS One; 2015; 10(9):e0138789. PubMed ID: 26393512
[TBL] [Abstract][Full Text] [Related]
15. HDM2 regulation by AURKA promotes cell survival in gastric cancer.
Sehdev V; Katsha A; Arras J; Peng D; Soutto M; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W
Clin Cancer Res; 2014 Jan; 20(1):76-86. PubMed ID: 24240108
[TBL] [Abstract][Full Text] [Related]
16. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
Sehat B; Andersson S; Girnita L; Larsson O
Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
18. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
Hong SY; Shih YP; Li T; Carraway KL; Lo SH
Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
[TBL] [Abstract][Full Text] [Related]
19. Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
Zhang S; Sun Y
EBioMedicine; 2020 Apr; 54():102718. PubMed ID: 32268269
[No Abstract] [Full Text] [Related]
20. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
